TINJAUAN PUSTAKA II revisi 2.me.docx

7/27/2019 TINJAUAN PUSTAKA II revisi 2.me.docx

http://slidepdf.com/reader/full/tinjauan-pustaka-ii-revisi-2medocx 1/4

TINJAUAN PUSTAKA II

TERAPI KOMBINASI ASMA

Oleh

Hendra Agus Setiawan

NIM. S601007002

Pembimbing

DR. Eddy Surjanto, dr., SpP(K)

PROGRAM PENDIDIKAN DOKTER SPESIALIS

PULMONOLOGI DAN ILMU KEDOKTERAN RESPIRASI

FK UNS/ RSUD Dr. MOEWARDI

SURAKARTA

2013

Kepada Yth :



DAFTAR PUSTAKA

1. Perhimpunan Dokter Paru Indonesia. Asma pedoman diagnosis dan

penatalaksanaan di Indonesia. Jakarta: Perhimpunan Dokter Paru

Indonesia;2004. p. 1-79.

2. Global Initiative for Asthma. Global strategy for asthma management and

prevention. Vancouver: GINA Executive Committee University of British

Columbia;2012. p. 1-77.

3. Barnes JP. Drugs for asthma. British Journal of

Pharmacology.2006;147:297-303.4. O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y,

EkstrŌm T, Bateman ED. Budesonide/Formoterol combination therapy as

both maintenance and reliever medication in asthma. American Journal Of

Respiratory And Critical Care Medicine.2005;171:129-136.

5. Mahajan S, Mehta AA. Role of cytokines in pathophysiology of asthma.

iranian journal of pharmacology and therapeutics.2006;5:1-5.

6. Barnes JP. Pathophysiology of asthma. Eur Respir Journal.2003;23:84-113.

7. National Heart, Lung, And Blood Institute. Guidelines for the diagnosis and

management of asthma. US Department of Health and Human

Service.2007;213-79.

8. Hewrylowicz CM, Garra AO. Potential role of interleukin-10-secreting

regulatory T cells in allergy and asthma. Nature Reviews

Immunology.2005;5:271-83.

9. Carol P, Gaspard KJ. Alterations in respiratory function: disorders of gas

exchange. essentials of pathophysiology. Philladelphia: Lippincott Williams

& Wilkins;2004. p. 376-99.

10. Monteseirin J. Neutrophils and Asthma. J Investig Allergol Clin

Immunol.2009;19(5): 340-54. 11. Marone G, Triggiani M, de Paulis A. Mast Cells and basophils : friends as

well as foes in bronchiale asthma. Elseviere Trends of

Immunology.2005;25(1): 25-31.



12. Motuschi P. Role of leukotrienes and leukotrienens modifier in asthma.

Pharmaceuticals journal.2010;3:1792-811.

13. Zervas E, Oikonomidou E, Kainis E, Kokkala M, Petroheilou K, Gaga L.

Control of asthma : review. therapy advances in respiratory disease.2008;2:

141-8. 14. Asthma Control Test. GlaxoSmithKline. [cited 2013 May 19th]. Available

from : http://www.asthma.com/assets/pdf/asthma_act_adult.pdf . 15. Bjermer L. Evaluating combination therapies for asthma : pros, cons, and

comparative benefits reviews. therapy advances in respiratory

disease.2008;2:149-61.

16. Guidelines for the diagnosis and management of asthma expert panel report

2. National Institute of Health Pub.1997;97:1-98.

17. What are the combination drugs? American Thoracic Society. [cited 2013

March 2nd]. Available from:

http://www.thoracic.org/clinical/copd-guidelines/for-patients/what-kind-of-

medications-are-there-for-copd/what-are-combination-drugs.php.

18. Montuschi P, Pagliari G, Fuso L. Pharmacotherapy of asthma : regular

treatment or on demand? Ther Adv Respir Dis.2009;3(4): 175-91.

19. Larsson AM, Selroos O. Advances in asthma and copd treatment:

combination therapy with inhaled corticosteroids and long-acting β2-

agonists. Current Pharmaceutical Design.2006;12:3261-79.

20. Asthma Management Handbook. National Asthma Council.Australia.6th ed.

Melbourne: NACA.2006.p. 5-59

21. Worsnop C. Combination inhalers for asthma. Australian Prescriber.2006;

2:26-8.

22. Norris SL, McNally TK, Thakurta S. Drugs class review quick-relief

medications for asthma. Oregon Health and Science University.

Portland.2008. p.17-30.

23. Curran D, Daughaday C, Kachikian D, Littner M, Sees G. Management of

asthma in children and adults. Department of Veterans Affairs Department

of Defense.2009;p.16-88.



24. Katzung BG, Masters SB, Trevor AJ. Drugs used in asthma. In: Katzung

BG, editors. Basic And Clinical Pharmacology. 11th ed. McGraw Hill

Lange.2009.p. 380-99.

25. Ritter JM, Lewis LD, Mant Timothy GK, Ferro A. Therapy of asthma ,

chronic obstructive pulmonary disease (copd). A text Book of Clinical

Pharmacology and Therapeutics. 5th ed. London: Hodder Arnold;2008.p

233-44.

26. Lindmark B. Differences in the pharmacodynamics of budesonide /

formoterol and salmeterol / fluticasone reflect differences in their

therapeutic usefulness in asthma. Therapeutic Advances in Respiratory

Disease.2008;2(5) 279 – 99.

27. Spahn JD, Cavar R. Glucokortikoid therapy in asthma. In: Lieberman P,

Anderson JA. Current Clinical Practice: Allergic Diseases: Diagnosis and

Treatment, 3rd Ed. Totowa: Humana Press;2006 p.385-401.

28. Chapman KR, Barnes NC, Greening AP, Jones PW, Pedersen S. Single

maintenance and reliever therapy (SMART) of asthma: a critical appraisal.

Thorax BMJ Journal.2010;10:1-6.

Komentator

(Yusfi Rydoka, dr)

Korektor

(Dewi M.)

TINJAUAN PUSTAKA II revisi 2.me.docx

Documents

Transcript of TINJAUAN PUSTAKA II revisi 2.me.docx